BeiGene Free Cash Flow vs Net Borrowings Analysis
| BGNE Stock | USD 187.50 20.12 9.69% |
BeiGene financial indicator trend analysis is way more than just evaluating BeiGene prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BeiGene is a good investment. Please check the relationship between BeiGene Free Cash Flow and its Net Borrowings accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.
Free Cash Flow vs Net Borrowings
Free Cash Flow vs Net Borrowings Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BeiGene Free Cash Flow account and Net Borrowings. At this time, the significance of the direction appears to have no relationship.
The correlation between BeiGene's Free Cash Flow and Net Borrowings is 0.0. Overlapping area represents the amount of variation of Free Cash Flow that can explain the historical movement of Net Borrowings in the same time period over historical financial statements of BeiGene, assuming nothing else is changed. The correlation between historical values of BeiGene's Free Cash Flow and Net Borrowings is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow of BeiGene are associated (or correlated) with its Net Borrowings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Borrowings has no effect on the direction of Free Cash Flow i.e., BeiGene's Free Cash Flow and Net Borrowings go up and down completely randomly.
Correlation Coefficient | 0.0 |
| Relationship Direction | Flat |
| Relationship Strength | Insignificant |
Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Net Borrowings
The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.Most indicators from BeiGene's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BeiGene current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.At present, BeiGene's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 17.4 B, whereas Sales General And Administrative To Revenue is forecasted to decline to 0.84.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 15.8M | 52.5M | 37.4M | 39.2M | Depreciation And Amortization | 46.5M | 66.3M | 87.7M | 92.1M |
BeiGene fundamental ratios Correlations
Click cells to compare fundamentals
BeiGene Account Relationship Matchups
High Positive Relationship
High Negative Relationship
BeiGene fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 1.6B | 5.6B | 8.6B | 6.4B | 5.8B | 3.2B | |
| Short Long Term Debt Total | 277.3M | 562.0M | 694.6M | 891.1M | 930.2M | 976.7M | |
| Other Current Liab | 152.7M | 445.7M | 705.6M | 538.8M | 739.8M | 776.8M | |
| Total Current Liabilities | 286.0M | 1.1B | 1.6B | 1.0B | 1.8B | 1.9B | |
| Total Stockholder Equity | 978.4M | 3.9B | 6.2B | 4.4B | 3.5B | 2.2B | |
| Other Liab | 57.1M | 443.3M | 562.5M | 283.7M | 326.3M | 342.6M | |
| Net Tangible Assets | 956.3M | 3.9B | 6.2B | 4.3B | 5.0B | 5.2B | |
| Property Plant And Equipment Net | 313.1M | 446.3M | 686.7M | 845.9M | 1.4B | 1.5B | |
| Net Debt | (340.7M) | (820.0M) | (3.7B) | (3.0B) | (2.2B) | (2.1B) | |
| Retained Earnings | (2.0B) | (3.6B) | (5.0B) | (7.1B) | (8.0B) | (7.6B) | |
| Accounts Payable | 122.5M | 232.0M | 168.0M | 294.8M | 315.1M | 330.9M | |
| Cash | 618.0M | 1.4B | 4.4B | 3.9B | 3.2B | 3.3B | |
| Non Current Assets Total | 439.6M | 640.1M | 1.0B | 845.9M | 1.6B | 1.7B | |
| Non Currrent Assets Other | 2.5M | 24.6M | 30.7M | (186.5M) | 35.7M | 37.5M | |
| Other Assets | 108.7M | 186.8M | 8.6B | 819.9M | 2.0 | 1.9 | |
| Long Term Debt | 240.7M | 183.6M | 202.1M | 209.1M | 197.6M | 143.1M | |
| Cash And Short Term Investments | 985.5M | 4.7B | 6.6B | 4.5B | 3.2B | 2.3B | |
| Common Stock Total Equity | 77K | 79K | 118K | 133K | 153.0K | 160.6K | |
| Common Stock Shares Outstanding | 60.1M | 83.5M | 92.8M | 103.1M | 104.4M | 72.1M | |
| Short Term Investments | 364.7M | 3.3B | 2.2B | 665.3M | 2.6M | 2.5M | |
| Liabilities And Stockholders Equity | 1.6B | 5.6B | 8.6B | 6.4B | 5.8B | 3.2B | |
| Non Current Liabilities Total | 347.9M | 656.3M | 803.4M | 977.9M | 457.8M | 376.4M | |
| Other Current Assets | 85.8M | 141.0M | 253.1M | 288.2M | 262.3M | 275.4M | |
| Other Stockholder Equity | 2.9B | 7.4B | 11.2B | 11.5B | 11.6B | 12.2B | |
| Total Liab | 633.9M | 1.7B | 2.4B | 2.0B | 2.3B | 2.4B | |
| Property Plant And Equipment Gross | 324.9M | 399.5M | 811.0M | 1.1B | 1.6B | 1.7B | |
| Total Current Assets | 1.2B | 5.0B | 7.6B | 4.7B | 4.2B | 2.6B | |
| Accumulated Other Comprehensive Income | (8.0M) | 6.9M | 18.0M | (77.4M) | (99.4M) | (94.5M) | |
| Short Term Debt | 10.8M | 362.8M | 471.4M | 377.1M | 732.3M | 768.9M | |
| Common Stock | 79K | 118K | 133K | 135K | 155.3K | 83.2K | |
| Property Plant Equipment | 324.9M | 357.7M | 587.6M | 955.9M | 1.1B | 1.2B | |
| Deferred Long Term Liab | 11.1M | 10.5M | 10.8M | 14.2M | 16.3M | 10.1M | |
| Long Term Debt Total | 189.7M | 240.7M | 183.6M | 202.1M | 232.4M | 156.4M | |
| Capital Surpluse | 2.7B | 2.9B | 7.4B | 11.2B | 12.9B | 13.5B | |
| Net Receivables | 72.8M | 79.7M | 500.2M | 173.2M | 395.9M | 415.7M | |
| Retained Earnings Total Equity | (1.0B) | (2.0B) | (3.6B) | (5.0B) | (4.5B) | (4.2B) | |
| Inventory | 28.6M | 89.3M | 242.6M | 282.3M | 416.1M | 436.9M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether BeiGene is a strong investment it is important to analyze BeiGene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BeiGene's future performance. For an informed investment choice regarding BeiGene Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BeiGene. If investors know BeiGene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BeiGene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.18) | Revenue Per Share 225.239 | Quarterly Revenue Growth 0.395 | Return On Assets (0.1) | Return On Equity (0.23) |
The market value of BeiGene is measured differently than its book value, which is the value of BeiGene that is recorded on the company's balance sheet. Investors also form their own opinion of BeiGene's value that differs from its market value or its book value, called intrinsic value, which is BeiGene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BeiGene's market value can be influenced by many factors that don't directly affect BeiGene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BeiGene's value and its price as these two are different measures arrived at by different means. Investors typically determine if BeiGene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BeiGene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.